Medtech start-up that aims to develop and market a range of innovative single-use surgical instruments called Cillar®.
Ostium Group has raised €3.8M across 1 funding round from 2 investors, most recently a round in Sep 2021. Based in Nantes, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-09-02 | Other | €3.8M |
| Bpifrance,Marle |
| View deal → |
